跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
6-H2
首页
药物
6-H2
6-H2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulations
申请人: WANG XUEBAO
优先权: 2005
US
TOOTHPASTE
申请人: OLYMPIC SPORTS TWELVEFOLD CROWNS HEALTH DEV HANGZHOU CO LTD
优先权: 2025
CN
WO
2 件公开
Pyridine Derivatives and Their Use in The Treatment of Psychotic Disorders
申请人: GLAXOSMITHKLINE LLC
优先权: 2005
CN
US
2 件公开
ANTI-NECTIN-4 ANTIBODIES AND METHODS OF USE THEREOF
申请人: ACT 225 BIOTHERAPEUTICS CORP
优先权: 2023
CN
WO
2 件公开
ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
申请人: IDEMITSU KOSAN CO
优先权: 2022
CN
Anti-tetanus toxin bispecific neutralizing antibody and related biological material and application thereof
申请人: INST MILITARY MEDICINE ACADEMY MILITARY SCIENCES PLA
优先权: 2025
CN
靶向LYPD3抗体制备及其在肿瘤免疫治疗中的应用
申请人: 苏州系统医学研究所
优先权: 2025
CN
ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
申请人: IDEMITSU KOSAN CO
优先权: 2022
WO
药物
反馈